Literature DB >> 15981481

Regulatory T cells in experimental colitis.

M Gad1.   

Abstract

Induction and maintenance of peripheral tolerance are important mechanisms to maintain the balance of the immune system. Growing evidence indicates that dysregulation of mucosal T cell responses may lead to loss of tolerance to commensal flora and to the development of inflammatory bowel diseases (IBD). Many studies suggest that active suppression of enteroantigen reactive cells mediated by regulatory T cells contributes to the maintenance of natural intestinal immune homeostasis. The use of the multiple animal models has not only improved our understanding of IBD, but also contributed to new suggestions of treatment strategies involving the use of regulatory T cells. The present review summarizes our current knowledge of regulatory T cells and their involvement in experimental IBD. The well-characterized SCID T cell transfer model and the naturally occurring regulatory CD4+CD25+ T cells are highlighted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981481     DOI: 10.1007/3-540-27702-1_9

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  9 in total

1.  Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells.

Authors:  Rafal Pacholczyk; Joanna Kern; Nagendra Singh; Makio Iwashima; Piotr Kraj; Leszek Ignatowicz
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

2.  Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells.

Authors:  Irina V Pinchuk; Ellen J Beswick; Jamal I Saada; Gushyalatha Boya; David Schmitt; Gottumukkala S Raju; Julia Brenmoehl; Gerhard Rogler; Victor E Reyes; Don W Powell
Journal:  Gastroenterology       Date:  2011-03-02       Impact factor: 22.682

3.  Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: mucosal crosstalk between stomach and distal intestine.

Authors:  Peter D R Higgins; Laura A Johnson; Jay Luther; Min Zhang; Kay L Sauder; Luz P Blanco; John Y Kao
Journal:  Inflamm Bowel Dis       Date:  2010-10-25       Impact factor: 5.325

Review 4.  Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature.

Authors:  Jay Luther; Maneesh Dave; Peter D R Higgins; John Y Kao
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

5.  In vivo imaging of mucosal CD4+ T cells using single photon emission computed tomography in a murine model of colitis.

Authors:  Bittoo Kanwar; Dong Wei Gao; Andrew B Hwang; James P Grenert; Simon P Williams; Benjamin Franc; Joseph M McCune
Journal:  J Immunol Methods       Date:  2007-10-16       Impact factor: 2.303

Review 6.  Helicobacter pylori infection and inflammatory bowel disease: is there a link?

Authors:  Konstantinos Papamichael; Panagiotis Konstantopoulos; Gerassimos J Mantzaris
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

Review 7.  Promises and paradoxes of regulatory T cells in inflammatory bowel disease.

Authors:  James D Lord
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

Review 8.  Spontaneous and transgenic rodent models of inflammatory bowel disease.

Authors:  Susan Prattis; Abdo Jurjus
Journal:  Lab Anim Res       Date:  2015-06-26

9.  Enlarged colitogenic T cell population paradoxically supports colitis prevention through the B-lymphocyte-dependent peripheral generation of CD4(+)Foxp3(+) Treg cells.

Authors:  Fábio Barrozo do Canto; Sylvia Maria Nicolau Campos; Alessandra Granato; Rafael F da Silva; Luciana Souza de Paiva; Alberto Nóbrega; Maria Bellio; Rita Fucs
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.